Vertex Pharmaceuticals Inc (VRTX)
484.17
-10.44
(-2.11%)
USD |
NASDAQ |
Nov 14, 16:00
483.70
-0.47
(-0.10%)
After-Hours: 17:11
Vertex Pharmaceuticals Gross Profit (Annual): 8.607B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.607B |
| December 31, 2022 | 7.850B |
| December 31, 2021 | 6.670B |
| December 31, 2020 | 5.469B |
| December 31, 2019 | 3.615B |
| December 31, 2018 | 2.638B |
| December 31, 2017 | 2.214B |
| December 31, 2016 | 1.492B |
| December 31, 2015 | 907.82M |
| December 31, 2014 | 519.43M |
| December 31, 2013 | 1.082B |
| December 31, 2012 | 1.247B |
| December 31, 2011 | 1.330B |
| December 31, 2010 | 130.64M |
| December 31, 2009 | 87.69M |
| December 31, 2008 | 159.82M |
| December 31, 2007 | 185.11M |
| Date | Value |
|---|---|
| December 31, 2006 | 204.19M |
| December 31, 2005 | 150.79M |
| December 31, 2004 | 97.07M |
| December 31, 2003 | 66.02M |
| December 31, 2002 | 91.44M |
| December 31, 2001 | 81.70M |
| December 31, 2000 | 106.35M |
| December 31, 1999 | 54.00M |
| December 31, 1998 | 33.60M |
| December 31, 1997 | 47.40M |
| December 31, 1996 | 21.80M |
| December 31, 1995 | 25.80M |
| December 31, 1994 | 23.10M |
| December 31, 1993 | 31.80M |
| December 31, 1992 | 6.60M |
| December 31, 1991 | 5.00M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
3.615B
Minimum
2019
8.607B
Maximum
2023
6.442B
Average
6.670B
Median
2021
Gross Profit (Annual) Benchmarks
| Eli Lilly and Co | 27.04B |
| Gilead Sciences Inc | 20.62B |
| Bristol-Myers Squibb Co | 34.31B |
| Moderna Inc | 2.061B |
| Sarepta Therapeutics Inc | 1.093B |